Skip to main content
Clinical Trials/EUCTR2013-003327-11-GB
EUCTR2013-003327-11-GBActive, not recruitingPhase 1

Alternative Treatments of Adult female Urinary Tract Infection: a double blind, placebo controlled,factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen. - ATAFUTI

niversity of Southampton0 sites382 target enrollmentStarted: December 17, 2014Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
382

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • Adult women (18-70) presenting to primary care with suspected lower urinary tract infection i.e. with at least one of dysuria, urgency or frequency.
  • Patient able to provide informed written consent.
  • Women willing to accept a delayed prescription for antibiotics.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 376
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1

Exclusion Criteria

  • Known or suspected pregnancy or breast feeding
  • In women of child bearing age a urine pregnancy test will usually be performed unless not indicated (for instance prior hysterectomy)
  • Known immunodeficiency state, long term corticosteroids therapy or chemotherapy
  • Has any of the following (A – F) known contra-indications or cautions to Ibuprofen and any as listed in the current SmPC:
  • A. Asthmatics sensitive to NSAIDS/ Ibuprofen or Aspirin
  • B. Severe heart failure and uncontrolled hypertension
  • C. Active gastro-intestinal ulceration or bleeding
  • D. Crohn’s disease or ulcerative colitis
  • E. Documented poor renal function
  • F. Chronic Kidney disease (Grade 3 - 5)
  • Currently or within 7 days taken antibiotics
  • Using a NSAID or Uva Ursi preparation and unwilling to discontinue for the study period
  • Suspected upper urinary tract infection (back pain, high fever>38C, systemic illness)
  • Women whom immediate antibiotics are otherwise indicated - frequent recurrent infection: >3 UTI episodes in past 12 months
  • Defect of the blood clotting system
  • Bladder surgery including cystoscopy in the last four weeks.
  • Currently taking Warfarin
  • Recruited to another interventional randomised control trial in previous 4 weeks.

Investigators

Sponsor
niversity of Southampton

Similar Trials

ATAFUTI - A Trial Investigating... | Clinical Trial